my ALT moved and I cannot work out whether dual agonist is why
Something I keep coming back to: my ALT moved and I cannot work out whether dual agonist is why. Imaging-derived liver fat fraction is a surrogate. It correlates with histology imperfectly, and a trial reporting one is not reporting the other. Nothing containing this compound is approved anywhere. Research-use-only…
Looked for independent results across this whole site and found almost none. Worth knowing before forming an opinion.
Looked for independent results across this whole site and found almost none.
Agreed — and the endpoint definitions are where the actual claim lives.
Correction: that is the imaging endpoint, not the histological one. The paper reports both and they differ substantially.
Are you reading the publication or a summary?
This. Biopsy-confirmed and imaging-suggested are different evidentiary categories and get run together constantly.
Yes — nothing containing this is approved anywhere, which is the first fact and usually the last one mentioned.
this board is small because the compound is early
What does the tolerability table say at that dose?
Which phase and which arm are you quoting?